MASLD
-
healthMASLD Redefined: Expert Insights on Multisystem Liver Disease and Future Therapies
Sven Francque discusses the paradigm shift in MASLD treatment at EASL 2026, emphasizing multisystem care, diagnostic gaps, and the future of combination therapies for metabolic liver disease.
-
healthEASL 2026: Rethinking MASLD as a Multisystem Disorder
Sven Francque discusses the paradigm shift in MASLD treatment, emphasizing multisystem care, diagnostic gaps, and individualized pharmacological strategies at EASL 2026.
-
healthThe Silent Threat: What Women Need to Know About Liver Disease
Liver disease affects millions of US adults, with women at higher risk. Understand causes, symptoms, and stages.
-
healthThe Silent Threat: Understanding Liver Disease in Women
Learn about chronic liver disease, its stages, symptoms, and causes, with a focus on risks for women.
-
healthKetogenic Diet Dramatically Slashes Liver Fat in MASLD Patients
A very low-energy ketogenic diet significantly reduced liver fat by 77% in MASLD patients, far surpassing a Mediterranean diet in a pilot study.
-
healthBinge Drinking Once Monthly Triples Liver Fibrosis Risk in MASLD Patients
New US study reveals that episodic heavy drinking significantly elevates liver fibrosis risk for individuals with metabolic dysfunction-associated steatotic liver disease.
-
healthMASLD Drives Rise in Cirrhosis Across Northern Mexico
Metabolic dysfunction-associated steatotic liver disease (MASLD) now leads chronic liver disease in northeastern Mexico, linked to rising obesity and diabetes.
-
healthObesity Drives Advanced Liver Disease-New Treatments Emerge
Obesity is now a leading cause of cirrhosis and liver cancer. Weight loss and GLP-1 drugs show promise in halting progression.